Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABUS | AMGN | VRTX | GILD | BMY |
| Company | Arbutus Biopharma Corp | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.96 | 320.58 | 473.91 | 89.49 | 54.33 |
| High | 3.96 | 320.58 | 475.48 | 90.71 | 55.77 |
| Low | 3.86 | 314.61 | 468.77 | 89.37 | 54.32 |
| Last | 3.87 | 316.91 | 472.80 | 89.84 | 55.45 |
| Change | -0.09 | -2.31 | +1.68 | +0.33 | +1.13 |
| % Change | -2.27% | -0.72% | +0.36% | +0.37% | +2.08% |
| Volume | 930,646 | 2,085,406 | 1,239,483 | 6,052,627 | 10,773,717 |
| 20-Day Average Volume | 804,732 | 1,720,870 | 1,052,134 | 5,184,901 | 8,744,141 |
| Previous Close | 3.96 | 319.22 | 471.12 | 89.51 | 54.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.98 | 319.64 | 476.86 | 87.27 | 53.06 |
| 20-Day Raw Stochastic | 28.40% | 33.87% | 45.21% | 86.71% | 84.66% |
| 20-Day Relative Strength | 46.54% | 45.54% | 49.20% | 68.89% | 62.68% |
| Weighted Alpha | +96.57 | +15.56 | +22.99 | +26.90 | +16.83 |
| Today's Opinion | 40% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 56% Buy | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.44% since 10/28/24 | -0.08% since 10/28/24 | -0.75% since 10/28/24 | +1.22% since 10/28/24 | +5.34% since 10/28/24 |
| Low | 3.80 on 11/01/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 86.81 on 10/29/24 | 52.14 on 10/29/24 |
| High | 4.05 on 10/29/24 | 323.40 on 10/31/24 | 478.06 on 10/29/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | +0.78% since 10/04/24 | -0.86% since 10/04/24 | +3.84% since 10/04/24 | +6.21% since 10/04/24 | +2.76% since 10/04/24 |
| Low | 3.68 on 10/10/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 4.35 on 10/16/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | +3.61% since 08/02/24 | -5.11% since 08/02/24 | -4.38% since 08/02/24 | +17.02% since 08/02/24 | +13.70% since 08/02/24 |
| Low | 3.30 on 08/05/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 4.72 on 09/09/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | +42.80% since 05/03/24 | +1.81% since 05/03/24 | +17.88% since 05/03/24 | +38.68% since 05/03/24 | +26.05% since 05/03/24 |
| Low | 2.70 on 05/06/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 4.72 on 09/09/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 747,577 | 171,526,160 | 121,597,008 | 111,439,232 | 110,128,096 |
| Shares Outstanding, K | 188,782 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 18,140,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -72,850,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 1,730,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -19,800,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.92 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/01/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.66 | 0.00 | 18.90 | 47.67 |